Venetoclax and hypomethylating agents versus tagraxofusp in older patients with blastic plasmacytoid dendritic cell neoplasm. Lee BJ. Ann Hematol 2025;104:2069-2071.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee BJ. Venetoclax and hypomethylating agents versus tagraxofusp in older patients with blastic plasmacytoid dendritic cell neoplasm. Ann Hematol 2025;104:2069-2071.
PMID: 39971776